OncoImmunity AS today announced that it has been acquired by NEC Corporation, the renowned Japanese IT and network company, that recently launched its Artificial Intelligence (AI) driven drug discovery business. OncoImmunity AS will now become a subsidiary of NEC and operate under the name of NEC OncoImmunity AS. OncoImmunity AS, founded in 2014, develops software that […]
San Mateo, CA, United States – BlueBee is pleased to announce the expansion of its senior management team with the appointment of Pam Cheng, Ph.D., as Vice President of Product Management and Strategy. Pam joins BlueBee with expertise in clinical bioinformatics honed from her years of experience at Illumina, Complete Genomics, and Agilent Technologies. As a […]
Cambridge, United Kingdom – 22 July 2019 – Congenica, a digital health company enabling accelerated genomic data interpretation, today announced it has renamed its software platform Congenica® and expanded its capabilities to include CNV calling for exome and gene panel sequencing. The latest software version will continue to streamline and enhance genomic clinical interpretation and help to reduce […]
Paris Atos, a global leader in digital transformation, was selected by GCS AURAGEN[1] – to provide and orchestrate the high-performance computing infrastructure and storage of a new genomic pilot platform for high-flow sequencing calculation. This platform has been selected as part of the French national plan for Genomic Science (‘France Médecine Génomique 2025’[2]). Atos will manage […]
PRINCETON, NJ – Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced that the entire staff from Compass Strategic Consulting (Compass) has joined Certara’s Evidence & Access group. Certara Evidence & Access was formed through the acquisition of Analytica Laser (market access, health economics and real-world […]
PRINCETON, NJ – Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced that it has formed a new practice area called Certara Global Health (CGH) to focus its technological expertise on helping to achieve equity in health for all people worldwide. CGH is a new product […]
Genedata E2E software solution to increase speed and efficiency of discovery and development of Genmab’s next-generation cancer therapies Basel, Switzerland ‒ Genedata, a leading provider of advanced software solutions for biopharmaceutical R&D, today announced that Genmab, an international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer, […]
DRVISION wins NIMH SBIR grant to develop the Intelligent Connectomics Analysis platform within Aivia
DRVISION wins up to 3.27 million USD NIMH SBIR grant to develop the Intelligent Connectomics Analysis platform within Aivia BELLEVUE, WA, UNITED STATES — DRVISION Technologies, a pioneer in computer vision and the world’s leading AI microscopy software company has been awarded up to 3.27 million USD from the National Institute of Mental Health (NIMH) to […]
Acquisition strengthens Bruker’s portfolio of high-performance PET molecular imaging solutions ZURICH, Switzerland — Bruker today announced that it has acquired PMOD Technologies LLC, a highly respected provider of research-use-only software for preclinical and molecular imaging, with a focus on molecular quantification and pharmacokinetic modeling. The PMOD software is widely used for the analysis of positron […]
Tokyo, Japan – Hitachi High-Technologies Corporation (TSE: 8036, Hitachi High-Tech) announced that Hitachi High Technologies America, Inc. (CEO: Craig Kerkove), a subsidiary of Hitachi High-Tech, will team with SparkCognition, Inc. (CEO: Amir Husain, “SparkCognition”) to deploy SparkCognition’s proprietary automated machine learning modeling platform, Darwin, at Hitachi High-Tech Group’s customers in Japan and other areas in […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
